| 1. |
- Archer, John, et al.
(författare)
-
Perpetrator programmes for partner violence : A rejoinder to Respect
- 2012
-
Ingår i: Legal and Criminological Psychology. - : Wiley. - 1355-3259 .- 2044-8333. ; 17:2, s. 225-232
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose. To reply to the comments made by Debbonaire and Todd (2012) in relation to our critique of Respect's Position Statement. Method. We examined their reply in relation to our original article and to the wider research literature. Results. We show that Debbonaire and Todd's reply is largely a series of assertions, for which little or no supporting evidence is offered. Their argument is first that we are misplaced in criticizing their Position Statement, and second that the main points of the statement are defendable. We indicate why our criticisms of the statement still stand. Conclusions. We argue that Respect have not countered our overall criticism of their position that intimate partner violence (IPV) can only be addressed as a gendered issue, that is as a consequence of patriarchal values enacted at the individual level. Instead we advocate a gender-inclusive approach applying a knowledge base derived from robust empirical research on IPV and more widely from research on human aggression.
|
|
| 2. |
- Hayes, Steven C., et al.
(författare)
-
Report of the ACBS Task Force on the strategies and tactics of contextual behavioral science research
- 2021
-
Ingår i: Journal of Contextual Behavioral Science. - : Elsevier. - 2212-1447. ; 20, s. 172-183
-
Tidskriftsartikel (refereegranskat)abstract
- Throughout its history the strategy and tactics of contextual behavioral science (CBS) research have had distinctive features as compared to traditional behavioral science approaches. Continued progress in CBS research can be facilitated by greater clarity about how its strategy and tactics can be brought to bear on current challenges. The present white paper is the result of a 2 1/2-year long process designed to foster consensus among representative producers and consumers of CBS research about the best strategic pathway forward. The Task Force agreed that CBS research should be multilevel, process-based, multidimensional, prosocial, and pragmatic, and provided 33 recommendations to the CBS community arranged across these characteristics. In effect, this report provides a detailed research agenda designed to maximize the impact of CBS as a field. Scientists and practitioners are encouraged to mount this ambitious agenda.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Mercer, Louise K., et al.
(författare)
-
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project
- 2017
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 0003-4967 .- 1468-2060. ; 76:12, s. 2025-2030
-
Tidskriftsartikel (refereegranskat)abstract
- Background Lymphomas comprise a heterogeneous group of malignant diseases with highly variable prognosis. Rheumatoid arthritis (RA) is associated with a twofold increased risk of both Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). It is unknown whether treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) affect the risk of specific lymphoma subtypes.Methods Patients never exposed to (bionaïve) or ever treated with bDMARDs from 12 European biologic registers were followed prospectively for the occurrence of first ever histologically confirmed lymphoma. Patients were considered exposed to a bDMARD after having received the first dose. Lymphomas were attributed to the most recently received bDMARD.Results Among 124 997 patients (mean age 59 years; 73.7% female), 533 lymphomas were reported. Of these, 9.5% were HL, 83.8% B-cell NHL and 6.8% T-cell NHL. No cases of hepatosplenic T-cell lymphoma were observed. Diffuse large B-cell lymphoma (DLBCL) was the most frequent B-cell NHL subtype (55.8% of all B-cell NHLs). The subtype distributions were similar between bionaïve patients and those treated with tumour necrosis factor inhibitors (TNFi). For other bDMARDs, the numbers of cases were too small to draw any conclusions. Patients with RA developed more DLBCLs and less chronic lymphocytic leukaemia compared with the general population.Conclusion This large collaborative analysis of European registries has successfully collated subtype information on 533 lymphomas. While the subtype distribution differs between RA and the general population, there was no evidence of any modification of the distribution of lymphoma subtypes in patients with RA treated with TNFi compared with bionaïve patients.
|
|
